Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-27

FDA Approved: QUINAPRIL HCL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' supplemental application for Quinapril HCl and Hydrochlorothiazide, a fixed-dose combination for the treatment of hypert…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quinapril HCl and Hydrochlorothiazide (quinapril hydrochloride and hydrochlorothiazide)

Snippet

SUPPL AP for QUINAPRIL HCL AND HYDROCHLOROTHIAZIDE (QUINAPRIL HCL AND HYDROCHLOROTHIAZIDE)